{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:11Z","timestamp":1786994411626,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.msard.2023.104940","type":"journal-article","created":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T17:39:56Z","timestamp":1691948396000},"page":"104940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement"],"prefix":"10.1016","volume":"78","author":[{"given":"Zerrin","family":"Karaaslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fc\u015fra","family":"\u015eeng\u00fcl-Yediel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"Y\u00fcceer-Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"\u015eanl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Gezen-Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdin\u00e7","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Timirci-Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Tar\u0131k","family":"Baykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuslat","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recai","family":"T\u00fcrko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"K\u00fcrt\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuncay","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"G\u00fcrsoy-\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"\u0130smail K\u00fc\u00e7\u00fckali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2023.104940_bib0002","doi-asserted-by":"crossref","first-page":"13890","DOI":"10.1038\/s41598-020-70919-w","article-title":"Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"10","author":"Akaishi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2023.104940_bib0016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cryobiol.2020.04.001","article-title":"A proteomic approach towards understanding crypoprotective action of Me2SO on the CHO cell proteome","volume":"94","author":"Alanazi","year":"2020","journal-title":"Cryobiology"},{"issue":"8","key":"10.1016\/j.msard.2023.104940_bib0004","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ene.12759","article-title":"Antibody biomarkers in CNS demyelinating diseases - a long and winding road","volume":"22","author":"Berger","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2023.104940_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6496799","article-title":"SLC26A4 mutation promotes cell apoptosis by inducing pendrin transfer, reducing Cl(-) transport, and inhibiting PI3K\/Akt\/mTOR pathway","volume":"2022","author":"Dai","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"4-5","key":"10.1016\/j.msard.2023.104940_bib0003","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neurol.2016.03.003","article-title":"Neuromyelitis optica spectrum disorder (NMOSD): A new concept","volume":"172","author":"de Seze","year":"2016","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.msard.2023.104940_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104694","article-title":"Serum IgG of patients with relapsing inflammatory optic neuropathy immunoreacts with Sox2-positive glial cells of the optic nerve","volume":"73","author":"Erdag","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2023.104940_bib0026","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.msard.2023.104940_bib0013","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1567205016666190730155926","article-title":"Proteomics analysis of CA1 region of the hippocampus in pre-, progression and pathological stages in a mouse model of the alzheimer's disease","volume":"16","author":"Gurel","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.msard.2023.104940_bib0001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fneur.2020.00450","article-title":"Visualizing the central nervous system: imaging tools for multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"11","author":"Kuchling","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2023.104940_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.106911","article-title":"Kv5.1 antibody in epilepsy patients with unknown etiology","volume":"182","author":"Kucukali","year":"2022","journal-title":"Epilepsy Res."},{"issue":"10","key":"10.1016\/j.msard.2023.104940_bib0019","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1074\/jbc.M308444200","article-title":"The intracellular chloride ion channel protein CLIC1 undergoes a redox-controlled structural transition","volume":"279","author":"Littler","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.msard.2023.104940_bib0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.msard.2018.11.032","article-title":"Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity","volume":"28","author":"Masvekar","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2023.104940_bib0014","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jproteome.7b00464","article-title":"Scanning quadrupole data-independent acquisition, part A: qualitative and quantitative characterization","volume":"17","author":"Moseley","year":"2018","journal-title":"J. Proteome Res."},{"issue":"Pt 2","key":"10.1016\/j.msard.2023.104940_bib0021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2023.104940_bib0008","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/10790268.2019.1666238","article-title":"Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement","volume":"44","author":"Sen","year":"2021","journal-title":"J. Spinal Cord. Med."},{"issue":"1","key":"10.1016\/j.msard.2023.104940_bib0011","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12035-020-02114-x","article-title":"Gezen-Ak D. overexpression of alpha-synuclein reorganises growth factor profile of human astrocytes","volume":"58","author":"Sengul","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.msard.2023.104940_bib0024","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/187152711794488638","article-title":"Ion channels on microglia: therapeutic targets for neuroprotection","volume":"10","author":"Skaper","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"2","key":"10.1016\/j.msard.2023.104940_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1110740","article-title":"Potassium channel KIR4.1 as an immune target in multiple sclerosis","volume":"367","author":"Srivastava","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2023.104940_bib0009","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.104940_bib0018","doi-asserted-by":"crossref","first-page":"C1103","DOI":"10.1152\/ajpcell.00402.2001","article-title":"CLIC1 inserts from the aqueous phase into phospholipid membranes, where it functions as an anion channel","volume":"282","author":"Tulk","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.msard.2023.104940_bib0022","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5414\/NP301005","article-title":"Recurrent tumefactive demyelinating lesions: a pathological study","volume":"36","author":"Turkoglu","year":"2017","journal-title":"Clin. Neuropathol."},{"issue":"5-6","key":"10.1016\/j.msard.2023.104940_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000364904","article-title":"Aquaporin-1 antibody in neuromyelitis optical patients","volume":"72","author":"Tuzun","year":"2014","journal-title":"Eur. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2023.104940_bib0006","doi-asserted-by":"crossref","first-page":"e74773","DOI":"10.1371\/journal.pone.0074773","article-title":"Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders","volume":"8","author":"Tzartos","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.msard.2023.104940_bib0017","doi-asserted-by":"crossref","first-page":"12575","DOI":"10.1074\/jbc.272.19.12575","article-title":"Molecular cloning and expression of a chloride ion channel of cell nuclei","volume":"272","author":"Valenzuela","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.msard.2023.104940_bib0023","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.7150\/jca.59948","article-title":"Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.msard.2023.104940_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.msard.2023.104940_bib0027","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1177\/1352458517705479","article-title":"Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: two new cases","volume":"23","author":"Zhang","year":"2017","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823004418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823004418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:08:40Z","timestamp":1761901720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823004418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":27,"alternative-id":["S2211034823004418"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104940","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104940"}}